{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T17:59:36Z","timestamp":1711648776547},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1212\/wnl.51.2.548","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:35:18Z","timestamp":1336916118000},"page":"548-553","source":"Crossref","is-referenced-by-count":19,"title":["<i>APOE<\/i>\n            in non-Alzheimer amyloidoses"],"prefix":"10.1212","volume":"51","author":[{"given":"J.","family":"Chapman","sequence":"first","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cervena\u0301kova\u0301","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. B.","family":"Petersen","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-S.","family":"Lee","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Estupinan","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Richardson","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. L.","family":"Vnencak-Jones","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. C.","family":"Gajdusek","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Korczyn","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Brown","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. G.","family":"Goldfarb","sequence":"additional","affiliation":[{"name":"From the Clinical Neurogenetics Unit, Medical Neurology Branch (Drs. Chapman, Lee, and Goldfarb and J. Estupinan) and Laboratory of Central Nervous System Studies (Drs. Cervena\u0301kova\u0301 Gajdusek, and Brown), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (Drs. Chapman and Korczyn), Tel Aviv University, Ramat Aviv, Israel; Department of Pathology(Dr. Petersen and S. Richardson), Case Western Reserve University, Cleveland, OH;..."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91879-Q"},{"key":"e_1_3_1_3_2","first-page":"1","volume":"43","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele \u03f54 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.","journal-title":"Neurology"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.1"},{"key":"e_1_3_1_5_2","first-page":"5","volume":"19","year":"1996","unstructured":"Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 1996;19:53-77.","journal-title":"Annu Rev Neurosci"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.1.1"},{"key":"e_1_3_1_7_2","first-page":"5","volume":"99","year":"1997","unstructured":"Shimada K, Yasuda M, Maeda K. Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease. Seishin Shinkeigaku Zasshi 1997;99:575-587.","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"e_1_3_1_8_2","first-page":"5","volume":"11","year":"1993","unstructured":"Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interaction. Neuron 1993;11:575-580.","journal-title":"Neuron"},{"key":"e_1_3_1_9_2","first-page":"2","volume":"135","year":"1992","unstructured":"Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)91066-A"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(94)90139-2"},{"key":"e_1_3_1_12_2","first-page":"5","volume":"46","year":"1995","unstructured":"Goldfarb LG, Brown P. The transmissible spongiform encephalopathies. Annu Rev Med 1995;46:57-65.","journal-title":"Annu Rev Med"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91038-3"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91147-2"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91147-2"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)12024-X"},{"key":"e_1_3_1_17_2","first-page":"4","volume":"1","year":"1995","unstructured":"Friedman J, Gabizon R, Shapira A, et al. Association of apolipoprotein E4 alleles with Alzheimer's disease but not with Down syndrome or Creutzfeldt-Jakob disease. Alzheimer Res 1995;1:45-48.","journal-title":"Alzheimer Res"},{"key":"e_1_3_1_18_2","first-page":"1","volume":"53","year":"1996","unstructured":"Zerr I, Helmhold M, Poser S, Armstrong VW, Weber T. Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Arch Neurol 1996;53:1233-1238.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)11322-N"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350104"},{"key":"e_1_3_1_21_2","first-page":"4","volume":"7","year":"1991","unstructured":"Goldfarb LG, Brown P, Mitrova E, et al. Creutzfeldt-Jakob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur J Epidemiol 1991;7:477-486.","journal-title":"Eur J Epidemiol"},{"key":"e_1_3_1_22_2","first-page":"6","volume":"336","year":"1990","unstructured":"Goldfarb LG, Korcyzn AD, Brown P, Chapman J, Korczyn DC. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 1990;336:637. Letter.","journal-title":"Lancet"},{"key":"e_1_3_1_23_2","first-page":"2","volume":"31","year":"1992","unstructured":"Goldfarb LG, Brown P, Haltia M, et al. Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin. Ann Neurol 1992;31:274-281.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.1.1"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.1.1"},{"key":"e_1_3_1_26_2","first-page":"4","volume":"326","year":"1992","unstructured":"Medori R, Tritschler H-J, LeBlanc A, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992;326:444-449.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_27_2","first-page":"3","volume":"41","year":"1991","unstructured":"Brown P, Goldfarb LG, Brown WT, et al. Clinical and molecular genetic study of a large German kindred with Gerstmann-Str\u00e4ussler-Scheinker syndrome. Neurology 1991;41:375-379.","journal-title":"Neurology"},{"key":"e_1_3_1_28_2","first-page":"4","volume":"26","year":"1959","unstructured":"Gajdusek DC, Zigas V. Kuru: clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Guinea. Am J Med 1959;26:442-469.","journal-title":"Am J Med"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93327-6"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","unstructured":"Hixson JE Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31:545-548.","DOI":"10.1016\/S0022-2275(20)43176-1"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.1"},{"key":"e_1_3_1_32_2","first-page":"1","volume":"272","year":"1994","unstructured":"Wilson PFW, Myers RH, Larson MG, et al. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. JAMA 1994;272:1666-1671.","journal-title":"JAMA"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1995.tb01601.x"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360103"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91144-8"},{"key":"e_1_3_1_36_2","first-page":"4","volume":"53","year":"1994","unstructured":"Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437.","journal-title":"J Neuropathol Exp Neurol"},{"key":"e_1_3_1_37_2","first-page":"4","volume":"7","year":"1991","unstructured":"Goldfarb LG, Brown P, Mitrova E, et al. Creutzfeldt-Jakob disease associated with the PRNP codon 200Lys mutation: analysis of 45 families. Eur J Epidemiol 1991;7:477-486.","journal-title":"Eur J Epidemiol"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.1.1"},{"key":"e_1_3_1_39_2","first-page":"6","volume":"1","year":"1995","unstructured":"Spudich S, Mastrianni JA, Wrensch M, et al. Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med 1995;1:607-613.","journal-title":"Mol Med"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370703"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.12.1.1"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199406020-00001"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.2.548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:01:08Z","timestamp":1711551668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.2.548"}},"subtitle":["Transmissible spongiform encephalopathies"],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1212\/WNL.51.2.548"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.2.548","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}